Agilent Technologies, a renowned global leader in life sciences, diagnostics, and applied chemical markets, has recently unveiled its state-of-the-art Biopharma Experience Center in Hyderabad, Telangana. This significant investment underscores Agilent’s dedication to fostering biopharmaceutical innovation in India and around the world. The inauguration ceremony, graced by Telangana Minister for Information Technology, Electronics, Communications, and Industries Duddila Sridhar Babu, and Agilent’s President and CEO Padraig McDonnell, highlighted the pivotal role of the new center in advancing life sciences and healthcare innovation in Hyderabad. The cutting-edge facility is designed to support the entire drug development process, offering advanced lab technologies, expert training, and regulatory-ready workflows to facilitate the efficient and accelerated development of life-saving medications. By providing end-to-end solutions spanning key modalities such as chromatography, mass spectrometry, cell analysis, and lab informatics, the center enables companies to replicate real lab environments, ensure quality and compliance, and collaborate on market-ready solutions tailored to both local and global requirements.
Agilent’s CEO, Padraig McDonnell, emphasized the strategic importance of India as a growth market and Hyderabad’s pivotal role in biopharma innovation, reaffirming the company’s commitment to delivering integrated solutions that expedite the introduction of transformative therapies to the market. Minister Duddila Sridhar Babu lauded Hyderabad’s burgeoning healthcare and life sciences ecosystem, citing the city’s impressive roster of global pharma companies, healthcare chains, and FDA-approved manufacturing facilities. The launch of the Biopharma Experience Center aligns with the ‘Make-in-India’ initiative, empowering local innovation and fostering a sustainable healthcare landscape. This significant investment forms part of Agilent’s comprehensive three-to-five-year growth strategy for India, which includes expanding its presence, strengthening customer relationships, and positioning India as a key hub in the company’s global innovation roadmap. The recent establishment of the India Solution Center in Manesar further underscores Agilent’s commitment to enhancing its capabilities in one of its fastest-growing markets. Through collaborations with leading biopharma companies in India, Agilent aims to co-create innovative solutions that cater to the evolving needs of both local and global markets, solidifying its position as a trusted partner in driving biopharmaceutical advancements.
Read more from pharmabiz.com